Piper Sandler analyst Allison Bratzel raised the firm’s price target on Incyte (INCY) to $102 from $82 and keeps an Overweight rating on the shares. The firm notes the company shared strong Q3 results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results